Does CANRENONE Cause Therapy non-responder? 9 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Therapy non-responder have been filed in association with CANRENONE. This represents 3.2% of all adverse event reports for CANRENONE.
9
Reports of Therapy non-responder with CANRENONE
3.2%
of all CANRENONE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapy non-responder From CANRENONE?
Of the 9 reports.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANRENONE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does CANRENONE Cause?
Hyperkalaemia (68)
Hyponatraemia (35)
Hypotension (33)
Sopor (25)
Dehydration (24)
Syncope (23)
Drug interaction (21)
Bradycardia (19)
Drug ineffective (19)
Renal failure (19)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which CANRENONE Alternatives Have Lower Therapy non-responder Risk?
CANRENONE vs CANTHARIDIN
CANRENONE vs CAPECITABINE
CANRENONE vs CAPIVASERTIB
CANRENONE vs CAPLACIZUMAB
CANRENONE vs CAPLACIZUMAB-YHDP